跳至主要内容
临床试验/NCT00932581
NCT00932581已完成不适用

Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale

Teva Branded Pharmaceutical Products R&D, Inc.0 个研究点目标入组 110 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
主要终点
Scores on the UPDRS motor evaluation subscale are equivalent.

研究概览

简要总结

The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or Female at least 30 years of age
  • Willing to be assessed using the motor examination section of the UPDRS and the SPES/SCOPA motor evaluation
  • Patients must be willing and able to give written informed consent prior to performing an study procedures
  • Be in the "ON" State (only for patients who fluctuate between "ON" and "OFF" states)

排除标准

  • Absence of bradykinesia at the time of assessment
  • Hoehn and Yahr stage not available from patient's chart or not assessed between 3 and 180 days prior to clinic visit
  • Has received and experimental drug within the last thirty (30) days

结局指标

主要结局

Scores on the UPDRS motor evaluation subscale are equivalent.

时间窗: 4 months

次要结局

  • Correlations between the UPDRS motor examination bradykinesis subscale and the remaining UPDRS motor examination items, Hoeh and Yahr stage, Schwab and England scale, and SPES/SCOPA motor evaluation.(4 months)

研究者

申办方类型
Industry

相似试验